The epidemiology of Huntington's disease - PubMed (original) (raw)
Review
The epidemiology of Huntington's disease
P S Harper. Hum Genet. 1992 Jun.
Abstract
The available information on the world distribution of Huntington's disease (HD) from population surveys and death rate analysis is summarised and discussed in the light of genetic studies. It is concluded that most European populations, both Northern and Southern, show a relatively high prevalence (4-8 per 100,000), and that the disorder may also be frequent in India and parts of central Asia. HD is notably rare in Finland and in Japan, but data for Eastern Asia and Africa are inadequate. The disorder may have been underestimated in the American black population. Populations derived from recent European immigration show frequencies and origins of HD comparable to those expected from their own origins and expansion; there is no evidence to suggest that the HD gene has spread disproportionally and its selective effect may be close to neutral. Multiple separate introductions of the gene have been the rule in large populations. Several major foci of HD exist as the result of rapid population expansion. It is likely that a number of separate mutations for HD will be shown to be responsible for the disease, but that the high frequency of HD in European populations will prove to be the result of one or a very small number of mutations, probably of great antiquity.
Similar articles
- The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis.
Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N. Pringsheim T, et al. Mov Disord. 2012 Aug;27(9):1083-91. doi: 10.1002/mds.25075. Epub 2012 Jun 12. Mov Disord. 2012. PMID: 22692795 Review. - The epidemiology of Huntington's disease in Northern Ireland.
Morrison PJ, Johnston WP, Nevin NC. Morrison PJ, et al. J Med Genet. 1995 Jul;32(7):524-30. doi: 10.1136/jmg.32.7.524. J Med Genet. 1995. PMID: 7562964 Free PMC article. - Epidemiological Study of Huntington's Disease in the Province of Ferrara, Italy.
Carrassi E, Pugliatti M, Govoni V, Sensi M, Casetta I, Granieri E. Carrassi E, et al. Neuroepidemiology. 2017;49(1-2):18-23. doi: 10.1159/000479697. Epub 2017 Aug 12. Neuroepidemiology. 2017. PMID: 28803251 - Huntington's Disease-like 2 (HDL2) in North America and Japan.
Margolis RL, Holmes SE, Rosenblatt A, Gourley L, O'Hearn E, Ross CA, Seltzer WK, Walker RH, Ashizawa T, Rasmussen A, Hayden M, Almqvist EW, Harris J, Fahn S, MacDonald ME, Mysore J, Shimohata T, Tsuji S, Potter N, Nakaso K, Adachi Y, Nakashima K, Bird T, Krause A, Greenstein P. Margolis RL, et al. Ann Neurol. 2004 Nov;56(5):670-4. doi: 10.1002/ana.20248. Ann Neurol. 2004. PMID: 15468075 - [From gene to disease; HD gene and Huntington disease].
Maat-Kievit JA, Losekoot M, Roos RA. Maat-Kievit JA, et al. Ned Tijdschr Geneeskd. 2001 Nov 3;145(44):2120-3. Ned Tijdschr Geneeskd. 2001. PMID: 11723754 Review. Dutch.
Cited by
- Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes.
Baine FK, Kay C, Ketelaar ME, Collins JA, Semaka A, Doty CN, Krause A, Greenberg LJ, Hayden MR. Baine FK, et al. Eur J Hum Genet. 2013 Oct;21(10):1120-7. doi: 10.1038/ejhg.2013.2. Epub 2013 Mar 6. Eur J Hum Genet. 2013. PMID: 23463025 Free PMC article. - Huntington's disease and mitochondrial alterations: emphasis on experimental models.
Pérez-De la Cruz V, Carrillo-Mora P, Santamaría A. Pérez-De la Cruz V, et al. J Bioenerg Biomembr. 2010 Jun;42(3):207-15. doi: 10.1007/s10863-010-9289-4. J Bioenerg Biomembr. 2010. PMID: 20524050 - Obsessive-Compulsive Disorder Symptoms in Huntington's Disease: A Case Report.
Molano-Eslava JC, Iragorri-Cucalón A, Ucrós-Rodríguez G, Bonilla-Jácome C, Tovar-Perdomo S, Herin DV, Orozco-Cabal L. Molano-Eslava JC, et al. Rev Colomb Psiquiatr. 2008 Oct 1;37(4):644-654. doi: 10.1901/jaba.2008.37-644. Rev Colomb Psiquiatr. 2008. PMID: 19966930 Free PMC article. - Identification of molecular targets and small drug candidates for Huntington's disease via bioinformatics and a network-based screening approach.
Hossain MR, Tareq MMI, Biswas P, Tauhida SJ, Bibi S, Zilani MNH, Albadrani GM, Al-Ghadi MQ, Abdel-Daim MM, Hasan MN. Hossain MR, et al. J Cell Mol Med. 2024 Aug;28(16):e18588. doi: 10.1111/jcmm.18588. J Cell Mol Med. 2024. PMID: 39153206 Free PMC article. - Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?
Du X, Pang TY. Du X, et al. Front Psychiatry. 2015 Mar 9;6:32. doi: 10.3389/fpsyt.2015.00032. eCollection 2015. Front Psychiatry. 2015. PMID: 25806005 Free PMC article. Review.
References
- Nervenarzt. 1987 Jul;58(7):424-7 - PubMed
- Scott Med J. 1967 Apr;12(4):152-6 - PubMed
- S Afr Med J. 1988 Apr 16;73(8):489-94 - PubMed
- East Afr Med J. 1956 Jun;33(6):209-23 - PubMed
- Brain. 1967 Mar;90(1):203-32 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical